Affymax to Present at the J.P. Morgan Healthcare Conference
Affymax to Present at the J.P. Morgan Healthcare Conference
PALO ALTO, Calif.--(BUSINESS WIRE)-- Affymax, Inc. (NAS: AFFY) today announced that John Orwin, the company's chief executive officer, will present at the 31st Annual J.P. Morgan Healthcare Conference on Thursday, January 10, 2013 at 1:00 p.m. Pacific Time (4:00 p.m. Eastern Time) in San Francisco.
A live webcast of the presentation will be available on the investors section of the Company's website at http://www.investors.affymax.com/events.cfm. A replay will also be available for 30 days following the presentation.
About Affymax, Inc.
Affymax, Inc. is a biopharmaceutical company based in Palo Alto, California. Affymax's mission is to discover, develop and deliver innovative therapies that improve the lives of patients with kidney disease and other serious and often life-threatening illnesses.
The company's first marketed product, OMONTYS® (peginesatide) Injection, was approved by the U.S. Food and Drug Administration (FDA) in March 2012. For additional information, please visit www.affymax.com.
Affymax, Inc.
Alexandra Santos, 650-812-8961
Associate Director, Corporate Communications
KEYWORDS: United States North America California
INDUSTRY KEYWORDS:
The article Affymax to Present at the J.P. Morgan Healthcare Conference originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
